The European Myocardial Infarct Amiodarone Trial (EMIAT)
- 26 November 1993
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 72 (16) , F95-F98
- https://doi.org/10.1016/0002-9149(93)90970-n
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial InfarctionNew England Journal of Medicine, 1992
- Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study.Circulation, 1991
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillationJournal of the American College of Cardiology, 1989
- Prophylactic antiarrhythmic therapy of high-risk survivors of myocardial infarction: lower mortality at 1 month but not at 1 year.Circulation, 1987
- Digoxin Therapy and Mortality after Myocardial InfarctionNew England Journal of Medicine, 1986
- Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.Heart, 1985
- International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findingsJournal of the American College of Cardiology, 1984
- The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.Circulation, 1984
- Side effects of long-term amiodarone therapy.Circulation, 1983